D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 106 Citations 37,324 527 World Ranking 3859 National Ranking 379

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Endocrinology

Christoph Thiemermann mainly focuses on Internal medicine, Endocrinology, Nitric oxide, Nitric oxide synthase and Pharmacology. His Mechanism of action research extends to Internal medicine, which is thematically connected. The Endocrinology study combines topics in areas such as Necrosis and Receptor.

He interconnects Vasoconstriction, Biochemistry and Septic shock in the investigation of issues within Nitric oxide. The concepts of his Nitric oxide synthase study are interwoven with issues in Peroxynitrite, Lipopolysaccharide, Shock, Dexamethasone and Enzyme inhibitor. His Pharmacology research includes elements of Reactive oxygen species, Hemodynamics, Anesthesia and Lactate dehydrogenase.

His most cited work include:

  • Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase (1458 citations)
  • Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. (497 citations)
  • Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase (387 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Endocrinology, Pharmacology, Nitric oxide and Nitric oxide synthase. His Internal medicine study frequently links to other fields, such as Cardiology. His research integrates issues of Receptor, Endothelin receptor and Peroxisome proliferator-activated receptor in his study of Endocrinology.

Septic shock is closely connected to Shock in his research, which is encompassed under the umbrella topic of Pharmacology. Nitric oxide is frequently linked to Biochemistry in his study. The study incorporates disciplines such as Molecular biology and Enzyme inhibitor in addition to Nitric oxide synthase.

He most often published in these fields:

  • Internal medicine (42.19%)
  • Endocrinology (34.39%)
  • Pharmacology (29.18%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (42.19%)
  • Endocrinology (34.39%)
  • Sepsis (11.71%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Endocrinology, Sepsis, Inflammation and Intensive care medicine. His Internal medicine study combines topics in areas such as Resuscitation and Cardiology. Christoph Thiemermann focuses mostly in the field of Endocrinology, narrowing it down to matters related to Ejection fraction and, in some cases, Linagliptin.

His Sepsis research includes themes of Cardiac function curve, Pharmacology and Tumor necrosis factor alpha. His Inflammation study improves the overall literature in Immunology. His Organ dysfunction research integrates issues from Reperfusion injury and Ischemia.

Between 2013 and 2021, his most popular works were:

  • Abandon the mouse research ship? Not just yet! (103 citations)
  • Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis (92 citations)
  • Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis (75 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Inflammation

Christoph Thiemermann spends much of his time researching Sepsis, Intensive care medicine, Inflammation, Internal medicine and Endocrinology. His Sepsis study integrates concerns from other disciplines, such as Cardiac function curve and Tumor necrosis factor alpha. Christoph Thiemermann has researched Inflammation in several fields, including Diabetes mellitus, Receptor and Protein kinase B.

Christoph Thiemermann has included themes like IκB kinase, IκBα and Pharmacology in his Protein kinase B study. The concepts of his Endocrinology study are interwoven with issues in Diabetic cardiomyopathy and Mitochondrial biogenesis. As a member of one scientific family, Christoph Thiemermann mostly works in the field of Proinflammatory cytokine, focusing on Nitric oxide synthase and, on occasion, Kidney.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

Jane A. Mitchell;Pravit Akarasereenont;Christoph Thiemermann;Roderick J. Flower.
Proceedings of the National Academy of Sciences of the United States of America (1993)

2102 Citations

Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.

Christoph Thiemermann;John Vane.
European Journal of Pharmacology (1990)

712 Citations

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.

Nicole S Wayman;Yoshiyuki Hattori;Michelle C McDonald;Helder Mota-Filipe.
The FASEB Journal (2002)

530 Citations

Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase

Csaba Szabo;Garry J. Southan;Christoph Thiemermann.
Proceedings of the National Academy of Sciences of the United States of America (1994)

513 Citations

Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion

Edward J Sharples;Nimesh Patel;Paul Brown;Keith Stewart.
Journal of The American Society of Nephrology (2004)

507 Citations

Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.

Csaba Szabó;Jane A. Mitchell;Christoph Thiemermann;John R. Vane.
British Journal of Pharmacology (1993)

501 Citations

Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide

Christoph Thiemermann;Csaba Szabo;Jane A. Mitchell;John R. Vane.
Proceedings of the National Academy of Sciences of the United States of America (1993)

475 Citations

The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure

S. J. De Kimpe;Muralitharan Kengatharan;C. Thiemermann;J. R. Vane.
Proceedings of the National Academy of Sciences of the United States of America (1995)

435 Citations

Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle

Christoph Thiemermann;Joanne Bowes;Fiona P. Myint;John R. Vane.
Proceedings of the National Academy of Sciences of the United States of America (1997)

418 Citations

Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations

D. Frith;J. C. Goslings;C. Gaarder;M. Maegele.
Journal of Thrombosis and Haemostasis (2010)

405 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christoph Thiemermann

Salvatore Cuzzocrea

Salvatore Cuzzocrea

University of Messina

Publications: 246

Csaba Szabó

Csaba Szabó

University of Fribourg

Publications: 191

Emanuela Mazzon

Emanuela Mazzon

University of Messina

Publications: 152

Emanuela Esposito

Emanuela Esposito

University of Messina

Publications: 75

Achille P. Caputi

Achille P. Caputi

University of Messina

Publications: 72

Jane A. Mitchell

Jane A. Mitchell

National Institutes of Health

Publications: 65

Basilia Zingarelli

Basilia Zingarelli

Cincinnati Children's Hospital Medical Center

Publications: 64

Ping Wang

Ping Wang

Feinstein Institute for Medical Research

Publications: 57

Timothy R. Billiar

Timothy R. Billiar

University of Pittsburgh

Publications: 55

Mauro Perretti

Mauro Perretti

Queen Mary University of London

Publications: 44

Daniela Salvemini

Daniela Salvemini

Saint Louis University

Publications: 42

Lucas Liaudet

Lucas Liaudet

University of Lausanne

Publications: 36

Irshad H. Chaudry

Irshad H. Chaudry

University of Alabama at Birmingham

Publications: 35

Thomas Hartung

Thomas Hartung

Johns Hopkins University

Publications: 35

Seung Hyun Han

Seung Hyun Han

Seoul National University

Publications: 30

Pal Pacher

Pal Pacher

National Institutes of Health

Publications: 29

Trending Scientists

Alexander Tuzhilin

Alexander Tuzhilin

New York University

Michael G. Safonov

Michael G. Safonov

University of Southern California

Gerhard H. Jirka

Gerhard H. Jirka

Karlsruhe Institute of Technology

Shinji Inagaki

Shinji Inagaki

Toyota Motor Corporation (Japan)

Kenneth I. Ozoemena

Kenneth I. Ozoemena

University of the Witwatersrand

Yongxiang Li

Yongxiang Li

RMIT University

Antonis E. Koromilas

Antonis E. Koromilas

McGill University

Stefano Stifani

Stefano Stifani

Montreal Neurological Institute and Hospital

Zoltan Szallasi

Zoltan Szallasi

Boston Children's Hospital

Massimo Vitale

Massimo Vitale

University of Genoa

Jung Mogg Kim

Jung Mogg Kim

Hanyang University

Anthony S. Kiem

Anthony S. Kiem

University of Newcastle Australia

Robert P. Myers

Robert P. Myers

University of Calgary

Robert M. Berne

Robert M. Berne

University of Virginia

Terry Connolly

Terry Connolly

University of Arizona

Ian A. Bond

Ian A. Bond

Massey University

Something went wrong. Please try again later.